Tier 1 — highest

Vitamin K2 and D3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial

Selma Hasific, Kristian Altern Øvrehus, Anna Mejldal, Susanne Hosbond, Jess Lambrechtsen, Preman Kumarathurai, Damini Dey, Emil Johannes Ravn, Lars Melholt Rasmussen, Oke Gerke, Hans Mickley, Axel Diederichsen
Circulation 2026 :10.1161/CIRCULATIONAHA.126.082363

Bibliography

PubMed
PMID 42661461
Trial registry
View on ClinicalTrials.gov Registered trial — results not yet published in a peer-reviewed journal.
Funding
Funding attribution is not supplied in the indexed abstract; consult the linked original publication.
Competing interests
Consult the original publication for competing-interest declarations; the indexed record does not provide a concise declaration.

Study snapshot

DesignMulticenter randomized double-blind placebo-controlled clinical trial
ModelHuman participants
Sample400 participants randomized; 398 included in the intention-to-treat analysis; median age 71 years; 30% women
Intervention720 micrograms/day MK-7 plus 25 micrograms/day vitamin D3, versus placebo
Duration24 months
EndpointsCoronary artery calcium-score progression; Coronary plaque composition in a CT angiography subset

What the study showed, in plain terms

In patients with severe coronary calcium, mean calcium-score increase was 196 Agatston units with K2/D3 and 248 with placebo. The between-group difference was -52 units (95% CI -79 to -24). In the angiography subset, calcified-plaque progression was lower, while total and noncalcified plaque-volume changes did not show the same between-group benefit.

Key findings

In patients with severe coronary calcium, mean calcium-score increase was 196 Agatston units with K2/D3 and 248 with placebo. The between-group difference was -52 units (95% CI -79 to -24). In the angiography subset, calcified-plaque progression was lower, while total and noncalcified plaque-volume changes did not show the same between-group benefit.

What this study can and cannot tell us

The intervention slowed progression of imaging measures; it did not remove existing calcium or establish fewer cardiovascular events. The high-calcium population and tested nutrient doses differ from general wellness use and many retail combination products.

Citation network

Articles citing this research paper

7 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified